Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Dieulafoy lesions and PHACE syndrome.

Kieswetter L, Walters TD, Lara-Corrales I, Carcao MD, Ngan B, Pope E.

Pediatr Dermatol. 2019 Nov;36(6):902-905. doi: 10.1111/pde.13922. Epub 2019 Jul 30.

PMID:
31359449
2.

Genetic determinants of VWF clearance and FVIII binding modify FVIII pharmacokinetics in pediatric hemophilia A patients.

Swystun LL, Ogiwara K, Rawley O, Brown C, Georgescu I, Hopman W, Labarque V, Male C, Thom K, Blanchette VS, Carcao MD, Lillicrap D.

Blood. 2019 Sep 12;134(11):880-891. doi: 10.1182/blood.2019000190. Epub 2019 Jul 26.

PMID:
31350267
3.

Abnormal fibrinolysis recognized by thromboelastography in a case of severe bleeding with normal coagulation and platelet function, leads to detection of a novel SERPINF2 variant causing severe alpha-2-antiplasmin deficiency.

Egan G, Pluthero FG, Bouskill V, Hilliard P, Drury LJ, Carcao MD, Kahr WHA.

Br J Haematol. 2019 Sep;186(6):e198-e201. doi: 10.1111/bjh.16077. Epub 2019 Jul 8. No abstract available.

PMID:
31282989
4.

Comparative pharmacokinetics of two extended half-life FVIII concentrates (Eloctate and Adynovate) in adolescents with hemophilia A: Is there a difference?

Carcao MD, Chelle P, Clarke E, Kim L, Tiseo L, Morfini M, Hossain T, Rand ML, Brown C, Edginton AN, Lillicrap D, Iorio A, Blanchette VS.

J Thromb Haemost. 2019 Jul;17(7):1085-1096. doi: 10.1111/jth.14469. Epub 2019 Jun 2.

PMID:
31038793
5.

Hemophilia in a Changing Treatment Landscape.

Pelland-Marcotte MC, Carcao MD.

Hematol Oncol Clin North Am. 2019 Jun;33(3):409-423. doi: 10.1016/j.hoc.2019.01.007. Epub 2019 Mar 29. Review.

PMID:
31030810
6.

Idiopathic pulmonary arterial hypertension - a unrecognized cause of high-shear high-flow haemostatic defects (otherwise referred to as acquired von Willebrand syndrome) in children.

Pelland-Marcotte MC, Humpl T, James PD, Rand ML, Bouskill V, Reyes JT, Bowman ML, Carcao MD.

Br J Haematol. 2018 Oct;183(2):267-275. doi: 10.1111/bjh.15530. Epub 2018 Aug 23.

PMID:
30141279
7.

NBEAL2 mutations and bleeding in patients with gray platelet syndrome.

Pluthero FG, Di Paola J, Carcao MD, Kahr WHA.

Platelets. 2018 Sep;29(6):632-635. doi: 10.1080/09537104.2018.1478405. Epub 2018 Jun 5. Review.

PMID:
29869935
8.

Glanzmann thrombasthenia platelets compete with transfused platelets, reducing the haemostatic impact of platelet transfusions.

Al-Battat S, Rand ML, Bouskill V, Lau W, Blanchette VS, Kahr WHA, Rivard GE, Carcao MD.

Br J Haematol. 2018 May;181(3):410-413. doi: 10.1111/bjh.14623. Epub 2017 May 3. No abstract available.

PMID:
28466602
9.

An International Prophylaxis Study Group (IPSG) survey of prophylaxis in inhibitor positive children/adults with severe haemophilia.

Carcao MD, Avila L, Leissinger C, Blanchette VS, Aledort L; Factor Utilization Expert Working Group of the International Prophylaxis Study Group (IPSG) and Participating Survey Investigators.

Haemophilia. 2017 Sep;23(5):e444-e447. doi: 10.1111/hae.13222. Epub 2017 Apr 24. No abstract available.

PMID:
28439934
10.

An International Prophylaxis Study Group (IPSG) survey of prophylaxis in adults with severe haemophilia.

Carcao MD, Avila L, Leissinger C, Blanchette VS, Aledort L.

Haemophilia. 2017 Sep;23(5):e447-e450. doi: 10.1111/hae.13238. Epub 2017 Apr 21. No abstract available.

PMID:
28429874
11.

Utility of factor VIII and factor VIII to von Willebrand factor ratio in identifying 277 unselected carriers of hemophilia A.

Labarque V, Perinparajah V, Bouskill V, Stain AM, Wakefield C, Manuel C, Blanchette VS, James PD, Lillicrap D, Carcao MD.

Am J Hematol. 2017 Jun;92(6):E94-E96. doi: 10.1002/ajh.24709. Epub 2017 Apr 6. No abstract available.

12.

Individualizing factor replacement therapy in severe hemophilia.

Carcao MD, Iorio A.

Semin Thromb Hemost. 2015 Nov;41(8):864-71. doi: 10.1055/s-0035-1552563. Epub 2015 Aug 13. Review.

PMID:
26270111
13.

Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades.

Nijdam A, Altisent C, Carcao MD, Cid AR, Claeyssens-Donadel S, Kurnik K, Ljung R, Nolan B, Petrini P, Platokouki H, Rafowicz A, Thomas AE, Fischer K; PedNet and CANAL study groups.

Haematologica. 2015 Mar;100(3):e84-6. doi: 10.3324/haematol.2014.115709. Epub 2014 Dec 19. No abstract available.

14.

Intracranial haemorrhage in von Willebrand disease: a report on six cases.

Labarque V, Stain AM, Blanchette V, Kahr WH, Carcao MD.

Haemophilia. 2013 Jul;19(4):602-6. doi: 10.1111/hae.12142. Epub 2013 Apr 5.

PMID:
23556472
15.

Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A.

Carcao MD, van den Berg HM, Ljung R, Mancuso ME; PedNet and the Rodin Study Group.

Blood. 2013 May 9;121(19):3946-52, S1. doi: 10.1182/blood-2012-11-469403. Epub 2013 Mar 12.

PMID:
23482934
16.

The diagnosis and management of congenital hemophilia.

Carcao MD.

Semin Thromb Hemost. 2012 Oct;38(7):727-34. doi: 10.1055/s-0032-1326786. Epub 2012 Sep 25. Review.

PMID:
23011791
17.

Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN).

Abshire TC, Federici AB, Alvárez MT, Bowen J, Carcao MD, Cox Gill J, Key NS, Kouides PA, Kurnik K, Lail AE, Leebeek FW, Makris M, Mannucci PM, Winikoff R, Berntorp E; VWD PN.

Haemophilia. 2013 Jan;19(1):76-81. doi: 10.1111/j.1365-2516.2012.02916.x. Epub 2012 Jul 23.

18.

Expanded phenotype-genotype correlations in a pediatric population with type 1 von Willebrand disease.

Robertson JD, Yenson PR, Rand ML, Blanchette VS, Carcao MD, Notley C, Lillicrap D, James PD.

J Thromb Haemost. 2011 Sep;9(9):1752-60. doi: 10.1111/j.1538-7836.2011.04423.x.

19.

DDAVP responsiveness in children with mild or moderate haemophilia A correlates with age, endogenous FVIII:C level and with haemophilic genotype.

Seary ME, Feldman D, Carcao MD.

Haemophilia. 2012 Jan;18(1):50-5. doi: 10.1111/j.1365-2516.2011.02572.x. Epub 2011 May 18.

PMID:
21592259
20.

Therapeutic consequences for misdiagnosis of type 2N von Willebrand disease.

Gupta M, Lillicrap D, Stain AM, Friedman KD, Carcao MD.

Pediatr Blood Cancer. 2011 Dec 1;57(6):1081-3. doi: 10.1002/pbc.23120. Epub 2011 Mar 21.

PMID:
21425451
21.

Dental disease in type 3 Von Willebrand disease: a neglected problem.

Carcao MD, Seary ME, Casas M, Winter L, Stain AM, Judd P.

Haemophilia. 2010 Nov;16(6):943-8. doi: 10.1111/j.1365-2516.2010.02344.x.

PMID:
20565545
22.

Side-effects and venous access issues with immune tolerance therapy.

Carcao MD.

Haemophilia. 2009 Mar;15(2):494-500.

PMID:
19347990
23.

The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey.

Biss TT, Chan AK, Blanchette VS, Iwenofu LN, McLimont M, Carcao MD; Association of Hemophilia Clinic Directors of Canada (AHCDC); Canadian Association of Nurses in Hemophilia Care (CANHC).

Haemophilia. 2008 Sep;14(5):923-30. doi: 10.1111/j.1365-2516.2008.01810.x. Epub 2008 Jul 14.

PMID:
18637844
24.

On-label versus off-label use of recombinant activated factor VII: a comprehensive review of use in two Canadian centers.

Carcao MD, Webert KE.

Semin Hematol. 2008 Apr;45(2 Suppl 1):S68-71. doi: 10.1053/j.seminhematol.2008.03.003. Review.

PMID:
18544429
25.

Intracranial bleeding in haemophilia beyond the neonatal period--the role of CT imaging in suspected intracranial bleeding.

Traivaree C, Blanchette V, Armstrong D, Floros G, Stain AM, Carcao MD.

Haemophilia. 2007 Sep;13(5):552-9.

PMID:
17880443
26.

Prophylaxis in the haemophilia population-optimizing therapy.

Carcao MD, Aledort LM; Round Table Group.

Haemophilia. 2007 May;13(3):227-32. No abstract available.

PMID:
17498070
27.

Definitions for haemophilia prophylaxis and its outcomes: the Canadian consensus study.

Ota S, Mclimont M, Carcao MD, Blanchette VS, Graham N, Paradis E, Feldman BM.

Haemophilia. 2007 Jan;13(1):12-20.

PMID:
17212719
28.

Clostridium septicum myonecrosis in congenital neutropenia.

Barnes C, Gerstle JT, Freedman MH, Carcao MD.

Pediatrics. 2004 Dec;114(6):e757-60.

PMID:
15574607
29.

Prophylactic factor replacement in hemophilia.

Carcao MD, Aledort L.

Blood Rev. 2004 Jun;18(2):101-13. Review.

PMID:
15010149
30.

Desmopressin (DDAVP) responsiveness in children with von Willebrand disease.

Revel-Vilk S, Schmugge M, Carcao MD, Blanchette P, Rand ML, Blanchette VS.

J Pediatr Hematol Oncol. 2003 Nov;25(11):874-9.

PMID:
14608197
31.

Central venous catheter-related thrombosis presenting as superior vena cava syndrome in a haemophilic patient with inhibitors.

Carcao MD, Connolly BL, Chait P, Stain AM, Acebes M, Massicotte P, Blanchette VS.

Haemophilia. 2003 Sep;9(5):578-83.

PMID:
14511297
32.

Intensive exposure to factor VIII is a risk factor for inhibitor development in mild hemophilia A.

Sharathkumar A, Lillicrap D, Blanchette VS, Kern M, Leggo J, Stain AM, Brooker L, Carcao MD.

J Thromb Haemost. 2003 Jun;1(6):1228-36. Review.

33.

Fcgamma receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpura.

Carcao MD, Blanchette VS, Wakefield CD, Stephens D, Ellis J, Matheson K, Denomme GA.

Br J Haematol. 2003 Jan;120(1):135-41.

PMID:
12492589
34.

Assessment of thrombocytopenic disorders using the Platelet Function Analyzer (PFA-100).

Carcao MD, Blanchette VS, Stephens D, He L, Wakefield CD, Butchart S, Christie DJ, Rand ML.

Br J Haematol. 2002 Jun;117(4):961-4.

PMID:
12060138
35.

DDAVP challenge tests in boys with mild/moderate haemophilia A.

Revel-Vilk S, Blanchette VS, Sparling C, Stain AM, Carcao MD.

Br J Haematol. 2002 Jun;117(4):947-51.

PMID:
12060135
36.

Identification of two new alpha-thalassemia mutations in exon 2 of the alpha1-globin gene.

Waye JS, Eng B, Patterson M, Carcao MD, Chang L, Olivieri NF, Chui DH.

Hemoglobin. 2001 Nov;25(4):391-6.

PMID:
11791872
37.

Hemoglobin H (Hb H) disease in Canada: molecular diagnosis and review of 116 cases.

Waye JS, Eng B, Patterson M, Walker L, Carcao MD, Olivieri NF, Chui DH.

Am J Hematol. 2001 Sep;68(1):11-5.

38.

von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.

Dean JA, Blanchette VS, Carcao MD, Stain AM, Sparling CR, Siekmann J, Turecek PL, Lillicrap D, Rand ML.

Thromb Haemost. 2000 Sep;84(3):401-9.

PMID:
11019962
39.

Compound heterozygosity for Hb S and Hb G-Copenhagen.

Carcao MD, Chang L, Poon A, Olivieri NF, Waye JS, Eng B, Patterson M, Chui DH.

Hemoglobin. 1999 Nov;23(4):379-81. No abstract available.

PMID:
10569728
40.

Use of the PFA-100 in the assessment of primary, platelet-related hemostasis in a pediatric setting.

Rand ML, Carcao MD, Blanchette VS.

Semin Thromb Hemost. 1998;24(6):523-9. Review.

PMID:
10066147
41.

Short-course oral prednisone therapy in children presenting with acute immune thrombocytopenic purpura (ITP).

Carcao MD, Zipursky A, Butchart S, Leaker M, Blanchette VS.

Acta Paediatr Suppl. 1998 Jun;424:71-4.

PMID:
9736224
42.

Renal-cell carcinoma in children: a different disorder from its adult counterpart?

Carcao MD, Taylor GP, Greenberg ML, Bernstein ML, Champagne M, Hershon L, Baruchel S.

Med Pediatr Oncol. 1998 Sep;31(3):153-8. Review.

PMID:
9722897
43.

Sequential use of intravenous and oral acyclovir in the therapy of varicella in immunocompromised children.

Carcao MD, Lau RC, Gupta A, Huerter H, Koren G, King SM.

Pediatr Infect Dis J. 1998 Jul;17(7):626-31.

PMID:
9686730
44.

The Platelet Function Analyzer (PFA-100): a novel in-vitro system for evaluation of primary haemostasis in children.

Carcao MD, Blanchette VS, Dean JA, He L, Kern MA, Stain AM, Sparling CR, Stephens D, Ryan G, Freedman J, Rand ML.

Br J Haematol. 1998 Apr;101(1):70-3.

PMID:
9576184

Supplemental Content

Loading ...
Support Center